Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ocular Oncology
•
Ophthalmology
•
Cornea and External Disease
How do you determine the role of adjunctive therapies for a patient with conjunctival squamous cell carcinoma (SCC) that has recurred after initial surgical excision?
Related Questions
How do you decide on treatment modality for ocular surface squamous neoplasia?
What are the advantages of using plexitome for treating recurrent corneal erosions compared with traditional methods?
How do you approach perioperative steroids for a quiescent uveitis patient undergoing cataract surgery?
How does CTAK compare to conventional keratoplasty techniques (PK/ALK) in patients with corneal ectasia?
What is the best course of treatment for limbal stem cell deficiency with a perforated corneal ulcer?
What is your approach to incorporating IPL therapy for meibomian gland dysfunction?
How do you approach IOL exchange in a patient who is unhappy after cataract surgery with a premium IOL?
How would you approach the management of a patient presenting with bilateral central corneal perforations following treatment with Ipilimumab/Nivolumab?
How do you predict which patients are most likely to have a positive response to Oxervate?
In patients with corneal edema and a glaucoma drainage tube placed in the AC, under what circumstances would you consider repositioning the tube in the sulcus first versus proceeding directly with endothelial keratoplasty alone?
